Back to MILLENNIUM MANAGEMENT LLC MILLENNIUM MANAGEMENT LLC

IKTIKT
6 quarters

Position history for MILLENNIUM MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC's holdings in INHIBIKASE THERAPEUTICS INC

Yes. Millennium Management holds 4,028,102 shares of IKT (Inhibikase Therapeutics), worth $8.2M, as of its Q2 2026 13F filing. It increased the position by 1,100,025 shares (+37.6%) from Q1 2026. Millennium Management has held IKT since Q4 2025, across 3 quarterly 13F filings.

Current Value

$8.2M

Current Shares

4M

Total Value Change

+$7.7M

Total Shares Change

+3.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4M
+37.6%
$8.2M0.0%$2.03
36
2026-Q1
Increased
2.9M
+1623.9%
$4.9M0.0%$1.91
43
2025-Q4
New
169,850
-
$348,1920.0%$1.97
33
2025-Q2
Exited
0
-100.0%
$00.0%$1.62
0
2025-Q1
Increased
913,502
+542.4%
$2M0.0%$2.29
42
2024-Q4
New
142,209
-
$462,1790.0%$3.24
33

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used